vimarsana.com

Page 20 - மறுபெயரிடு நிதி தகவல்தொடர்புகள் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

01 Communique Provides Quarterly Update on Business Developments and First Quarter Fiscal 2021 Results

01 Communique Provides Quarterly Update on Business Developments and First Quarter Fiscal 2021 Results
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

Alianza Minerals Increases Size of Gold in Soils Anomaly to over Three Kilometres at the Twin Canyon Project, Colorado, USA

Alianza Minerals Increases Size of Gold in Soils Anomaly to over Three Kilometres at the Twin Canyon Project, Colorado, USA 2020 soils survey expands anomalous gold values to over 3,000 metres of strike length in prospective Junction Creek Sandstone – Gold values 0.52 to 6.28 gt from underground grab samples – Drill program permitting underway Vancouver, BC TheNewswire – March 10, 2021 – Alianza Minerals Ltd. is pleased to report the results of the surface exploration program at the Twin Canyon Gold Project in southwestern Colorado. … (TheNewswire) – 2020 soils survey expands anomalous gold values to over 3,000 metres of strike length in prospective Junction Creek Sandstone – Gold values 0.52 to 6.28 g/t from underground grab samples

NeonMind Biosciences Inc: NeonMind Engages Pharma Executive Philippe Martin to Advance its Psilocybin Drug Candidates for Obesity

NeonMind Biosciences Inc: NeonMind Engages Pharma Executive Philippe Martin to Advance its Psilocybin Drug Candidates for Obesity NeonMind Biosciences Inc. ( FSE: 6UF) ( NeonMind ) is pleased to announce that on March 4, 2020 NeonMind engaged Philippe Martin as a drug development consultant. Figure 1: NeonMind Engages Pharma Executive Philippe Martin to Advance its Psilocybin Drug Candidates for Obesity To view an enhanced version of Figure 1, please visit: https://orders.newsfilecorp.com/files/7646/76539 neonmi2.jpg Mr. Martin has 20 years of biotechnology and pharmaceutical industry experience developing and commercializing innovative therapies in the fields of immunology, oncology and neurology. NeonMind has engaged Mr. Martin to advise on drug development programs and recommend critical resources for execution, as well as review and evaluate potential drug development paths to advance NeonMind s two psilocybin drug development programs.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.